Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On January 26, 2026, Milestone Pharmaceuticals Inc. issued a press release announcing the availability of CARDAMYST (etripamil) nasal spray for the
Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press Release dated January 26, 2026 104 Cover Page Interactive Data